Elizabeth K. O'donnell
Elite in Smoldering Multiple Myeloma

Dr. Elizabeth K. O'donnell

Internal Medicine | Oncology
Brigham and Women’s Hospital
Dana-Farber Brigham Cancer Center
75 Francis Street, 
Boston, MA 
Elite in Smoldering Multiple Myeloma
Brigham and Women’s Hospital
Dana-Farber Brigham Cancer Center
75 Francis Street, 
Boston, MA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Elizabeth O'donnell is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. O'donnell is rated as an Elite provider by MediFind in the treatment of Smoldering Multiple Myeloma. Her top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Orchiectomy, and Bone Marrow Aspiration.

Her clinical research consists of co-authoring 69 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 8 articles in the study of Smoldering Multiple Myeloma.

Graduate Institution
Vanderbilt University School Of Medicine, 2003 - 2007
Specialties
Internal Medicine
Oncology
Licenses
Internal Medicine in MA
Board Certifications
Internal Medicine
Medical Oncology
Fellowships
Dana Farber Cancer Institute******, 2010 - 2014
Hospital Affiliations
Massachusetts General Hospital
Brigham And Women's Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Tufts
  • HMO

Locations

Dana-Farber Brigham Cancer Center
75 Francis Street, Boston, MA 02115
Call: 617-632-6140
Other Locations
Dana-Farber Cancer Institute, Cancer Genetics and Prevention Clinic
450 Brookline Avenue, Boston, MA 02115
Call: 617-632-6140

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase II Study of Once Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Isatuximab in Newly Diagnosed, Transplant-Eligible Multiple Myeloma
A Phase II Study of Once Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Isatuximab in Newly Diagnosed, Transplant-Eligible Multiple Myeloma
Enrollment Status: Active_not_recruiting
Publish Date: August 29, 2025
Intervention Type: Drug
Study Drugs: Carfilzomib, Isatuximab, Lenalidomide, Dexamethasone
Study Phase: Phase 2
A Phase II Study of Lenalidomide, Ixazomib, Dexamethasone, and Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma
A Phase II Study of Lenalidomide, Ixazomib, Dexamethasone, and Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma
Enrollment Status: Active_not_recruiting
Publish Date: April 25, 2025
Intervention Type: Drug
Study Drugs: Lenalidomide, Ixazomib, Daratumumab Injection, Dexamethasone
Study Phase: Phase 2
Protocol H125001: An Open-Label Phase 1/2 Study of JCARH125, BCMA-targeted Chimeric Antigen Receptor (CAR) T Cells, in Subjects With Relapsed or Refractory Multiple Myeloma
Protocol H125001: An Open-Label Phase 1/2 Study of JCARH125, BCMA-targeted Chimeric Antigen Receptor (CAR) T Cells, in Subjects With Relapsed or Refractory Multiple Myeloma
Enrollment Status: Completed
Publish Date: May 24, 2024
Intervention Type: Biological
Study Drugs: JCARH125, JCARH125 + Anakinra
Study Phase: Phase 1/Phase 2
Phase II Study of Ibrutinib in Patients With Symptomatic, Previously Untreated Waldenstrom's Macroglobulinemia, and Impact on Tumor Genomic Evolution Using Whole Genome Sequencing
Phase II Study of Ibrutinib in Patients With Symptomatic, Previously Untreated Waldenstrom's Macroglobulinemia, and Impact on Tumor Genomic Evolution Using Whole Genome Sequencing
Enrollment Status: Completed
Publish Date: December 07, 2022
Intervention Type: Drug
Study Drug: Ibrutinib
Study Phase: Phase 2
Pilot Study to Assess Prolonged Nightly Fasting in Breast Cancer Survivors
Pilot Study to Assess Prolonged Nightly Fasting in Breast Cancer Survivors
Enrollment Status: Completed
Publish Date: July 21, 2022
Intervention Type: Behavioral
Study Phase: Not Applicable
A Pilot Study to Assess the Haymakers for Hope Fitness Program in Cancer Survivors
A Pilot Study to Assess the Haymakers for Hope Fitness Program in Cancer Survivors
Enrollment Status: Terminated
Publish Date: February 02, 2022
Intervention Type: Other
Study Phase: Not Applicable
View 5 Less Clinical Trials

69 Total Publications

Enhanced Risk Stratification of Smoldering Multiple Myeloma with Dynamic Biomarkers: A Multinational, Multicenter Study including 2,270 Participants (PANGEA 2.0).
Enhanced Risk Stratification of Smoldering Multiple Myeloma with Dynamic Biomarkers: A Multinational, Multicenter Study including 2,270 Participants (PANGEA 2.0).
Journal: Research square
Published: June 12, 2025
View All 69 Publications
Similar Doctors
Elite in Smoldering Multiple Myeloma
Dr. Omar Nadeem
Oncology
Elite in Smoldering Multiple Myeloma
Dr. Omar Nadeem
Oncology

Dana-Farber Cancer Institute, Lipper Multiple Myeloma Center

450 Brookline Avenue, 
Boston, MA 
 (0.1 miles away)
617-632-4852
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Omar Nadeem is an Oncologist in Boston, Massachusetts. Dr. Nadeem has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Smoldering Multiple Myeloma. His top areas of expertise are Smoldering Multiple Myeloma, Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Aspiration, and Bone Marrow Transplant.

Jacob P. Laubach
Elite in Smoldering Multiple Myeloma
Dr. Jacob P. Laubach
Oncology | Hematology
Elite in Smoldering Multiple Myeloma
Dr. Jacob P. Laubach
Oncology | Hematology

Dana-Farber Cancer Institute, Lipper Multiple Myeloma Center

450 Brookline Avenue, 
Boston, MA 
 (0.1 miles away)
617-632-4218
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jacob Laubach is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Laubach is rated as an Elite provider by MediFind in the treatment of Smoldering Multiple Myeloma. His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration.

Nikhil C. Munshi
Elite in Smoldering Multiple Myeloma
Dr. Nikhil C. Munshi
Oncology
Elite in Smoldering Multiple Myeloma
Dr. Nikhil C. Munshi
Oncology

Dana-Farber Cancer Institute, Lipper Multiple Myeloma Center

450 Brookline Avenue, 
Boston, MA 
 (0.1 miles away)
617-632-5607
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Nikhil Munshi is an Oncologist in Boston, Massachusetts. Dr. Munshi is rated as an Elite provider by MediFind in the treatment of Smoldering Multiple Myeloma. His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Castleman Disease, Relapsed Refractory Multiple Myeloma (RRMM), and Bone Marrow Aspiration.

VIEW MORE SMOLDERING MULTIPLE MYELOMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. O'donnell's expertise for a condition
ConditionClose
  • Elite
  • Monoclonal Gammopathy of Undetermined Significance (MGUS)
    Dr. O'donnell is
    Elite
    . Learn about Monoclonal Gammopathy of Undetermined Significance (MGUS).
    See more Monoclonal Gammopathy of Undetermined Significance (MGUS) experts
  • Multiple Myeloma
    Dr. O'donnell is
    Elite
    . Learn about Multiple Myeloma.
    See more Multiple Myeloma experts
  • Smoldering Multiple Myeloma
    Dr. O'donnell is
    Elite
    . Learn about Smoldering Multiple Myeloma.
    See more Smoldering Multiple Myeloma experts
  • Distinguished
  • Relapsed Refractory Multiple Myeloma (RRMM)
    Dr. O'donnell is
    Distinguished
    . Learn about Relapsed Refractory Multiple Myeloma (RRMM).
    See more Relapsed Refractory Multiple Myeloma (RRMM) experts
  • Schnitzler Syndrome
    Dr. O'donnell is
    Distinguished
    . Learn about Schnitzler Syndrome.
    See more Schnitzler Syndrome experts
  • Advanced
  • Germ Cell Tumor
    Dr. O'donnell is
    Advanced
    . Learn about Germ Cell Tumor.
    See more Germ Cell Tumor experts
  • Hypophosphatemia
    Dr. O'donnell is
    Advanced
    . Learn about Hypophosphatemia.
    See more Hypophosphatemia experts
  • Orchiectomy
    Dr. O'donnell is
    Advanced
    . Learn about Orchiectomy.
    See more Orchiectomy experts
  • Testicular Cancer
    Dr. O'donnell is
    Advanced
    . Learn about Testicular Cancer.
    See more Testicular Cancer experts
  • Waldenstrom Macroglobulinemia
    Dr. O'donnell is
    Advanced
    . Learn about Waldenstrom Macroglobulinemia.
    See more Waldenstrom Macroglobulinemia experts
  • Experienced
  • Agranulocytosis
    Dr. O'donnell is
    Experienced
    . Learn about Agranulocytosis.
    See more Agranulocytosis experts
  • B-Cell Lymphoma
    Dr. O'donnell is
    Experienced
    . Learn about B-Cell Lymphoma.
    See more B-Cell Lymphoma experts
  • Bone Marrow Aspiration
    Dr. O'donnell is
    Experienced
    . Learn about Bone Marrow Aspiration.
    See more Bone Marrow Aspiration experts
  • Cardiac Amyloidosis
    Dr. O'donnell is
    Experienced
    . Learn about Cardiac Amyloidosis.
    See more Cardiac Amyloidosis experts
  • Cerebral Amyloid Angiopathy
    Dr. O'donnell is
    Experienced
    . Learn about Cerebral Amyloid Angiopathy.
    See more Cerebral Amyloid Angiopathy experts
  • Chronic B-Cell Leukemia (CBCL)
    Dr. O'donnell is
    Experienced
    . Learn about Chronic B-Cell Leukemia (CBCL).
    See more Chronic B-Cell Leukemia (CBCL) experts
View All 25 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.